Bio-Gate AG

[{"orgOrder":0,"company":"Bio-Gate AG","sponsor":"Avicanna","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Avicanna and Bio-Gate Complete First Phase of Development on Cannabidiol (CBD) and MicroSilver BG\u2122 Based Skin Care Products","therapeuticArea":"Dermatology","highestDevelopmentStatus":"Phase I","country":"","productType":"Small molecule","productStatus":"Approved","date":"June 2021","year":"2021","type":"Not Applicable","leadProduct":"Cannabidiol","moa":"CB1\/CB2 receptor","url1":"","url2":"","graph1":"Dermatology","graph2":"Phase I","graph3":"Bio-Gate AG","amount2":0,"therapeuticAreaNew":"Dermatology","highestDevelopmentStatusNew":"Phase I","highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Dermatology","productSubType":"","amount2New":0,"dosageForm":"Topical","sponsorNew":"Bio-Gate AG \/ Bio-Gate","highestDevelopmentStatusID":"6","companyTruncated":"Bio-Gate AG \/ Bio-Gate"},{"orgOrder":0,"company":"Bio-Gate AG","sponsor":"Avicanna","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Avicanna Expands its Derma-Cosmetics Brand Pura H&W Into the European Union Through a Partnership with Bio-Gate AG","therapeuticArea":"Dermatology","highestDevelopmentStatus":"Approved","country":"","productType":"Small molecule","productStatus":"Approved","date":"April 2022","year":"2022","type":"Partnership","leadProduct":"Cannabidiol","moa":"CB1 receptor","url1":"","url2":"","graph1":"Dermatology","graph2":"Approved","graph3":"Bio-Gate AG","amount2":0,"therapeuticAreaNew":"Dermatology","highestDevelopmentStatusNew":"Approved","highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Dermatology","productSubType":"Controlled Substance","amount2New":0,"dosageForm":"Topical Gel","sponsorNew":"Bio-Gate AG \/ Bio-Gate AG","highestDevelopmentStatusID":"12","companyTruncated":"Bio-Gate AG \/ Bio-Gate AG"}]